Clinical Research Directory

1. Inclusion Criteria: 1. Clinical diagnosis of acute myocardial infarction. 2. Successful direct or emergency PCI of the infarct-related artery. 3. Ability to undergo randomization post-PCI. 4. Ability to understand and voluntarily sign the informed consent form. 2. Exclusion Criteria: 1. PCI failure (final TIMI flow \< grade 2) or presence of untreated severe stenosis. 2. Planned staged PCI or other cardiac surgery within 3 months. 3. Cardiogenic shock (Killip class IV), severe structural heart disease, or contraindications to PCI trial intervention. 4. Active bleeding or high bleeding risk. 5. Known allergy to the trial drug or its components. 6. ALT/AST \> 3x upper limit of normal (ULN); eGFR \< 30 mL/min/1.73 m². 7. Non-cardiovascular disease with life expectancy \< 1 year (e.g., active malignancy). 8. History of hemorrhagic stroke, or any ischemic stroke/transient ischemic attack within the past 6 months. 9. Requirement for long-term oral anticoagulation therapy. 10. Pregnancy, lactation, or women of childbearing potential not using effective contraception. 11. Current participation in another interventional clinical trial. 12. Any condition that may affect trial compliance, safety assessment, or result interpretation per investigator judgment.